Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus
- 1 September 1981
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 33 (3) , 840-847
- https://doi.org/10.1128/iai.33.3.840-847.1981
Abstract
Murine cytomegalovirus pools from various in vitro and in vivo sources were compared for virulence in suckling mice in an effort to identify the conditions which were necessary for the production of virulent and attenuated viruses. Virus passaged in tracheal ring and salivary gland organ cultures, where virus is produced primarily by epithelial cells, was even more attenuated than virus passaged in mouse embryo fibroblasts. The attenuation observed after passage in all three of these in vitro systems did not appear to be due to defective interfering particles. We also found that virus produced in vivo in salivary glands became attenuated with time after infection. Virus harvested from salivary glands 5 to 6 weeks after infection was highly attenuated compared with both salivary gland-passaged virus harvested 2 to 3 weeks after infection and tissue culture-passaged virus. The attenuation of salivary gland-passaged virus with time was reversed when animals were treated with cyclophosphamide before the virus was harvested. A comparison of virus pools harvested from susceptible and resistant mouse strains indicated that the mouse strain had little effect on the virulence of the virus produced. When the various sources of virus tested in this study were ranked in terms of the virulence of the virus produced, salivary glands in intact mice either 2 to 3 weeks after infection or after cyclophosphamide treatment produced the most virulent virus, followed by mouse embryo fibroblast cultures, tracheal ring and salivary gland organ cultures, and, finally, salivary glands in intact mice 5 to 6 weeks after infection.This publication has 26 references indexed in Scilit:
- Adverse Effects of Cytomegalovirus Vaccination in MiceJournal of Clinical Investigation, 1980
- Infection of Salivary Glands, Kidneys, Adrenals, Ovaries and Epithelia by Murine CytomegalovirusJournal of Medical Microbiology, 1979
- Activation of Latent Murine Cytomegalovirus Infection: Cocultivation, Cell Transfer, and the Effect of ImmunosuppressionThe Journal of Infectious Diseases, 1978
- Immunosuppression Reactivates and Disseminates Latent murine CytomegalovirusJournal of General Virology, 1977
- Murine Cytomegalovirus Infection of Epithelial Cells in Mouse Tracheal Ring Organ CultureThe Journal of Infectious Diseases, 1977
- Human Cytomegalovirus Immunization ProspectsNew England Journal of Medicine, 1977
- Clinical Trials of Immunization with the Towne 125 Strain of Human CytomegalovirusThe Journal of Infectious Diseases, 1976
- Infections with Cytomegalovirus in Bone Marrow Transplantation: Report of a WorkshopThe Journal of Infectious Diseases, 1975
- VACCINATION AGAINST CYTOMEGALOVIRUS?The Lancet, 1974
- DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED BY CYTOMEGALOVIRUS INFECTION IN UTEROThe Lancet, 1974